Neukio Biotherapeutics completed Series A-1 financing, to accelerate discovery and development of next generation cell therapy products
SHANGHAI, Sept. 2, 2022 /PRNewswire/ — Neukio Biotherapeutics, a company committed to developing novel cell therapy products, announces…